![Current and experimental treatments of Parkinson disease: A guide for neuroscientists - Oertel - 2016 - Journal of Neurochemistry - Wiley Online Library Current and experimental treatments of Parkinson disease: A guide for neuroscientists - Oertel - 2016 - Journal of Neurochemistry - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/cea7a0d1-4b84-4ff0-a629-d934ddbf83b5/jnc13750-fig-0002-m.jpg)
Current and experimental treatments of Parkinson disease: A guide for neuroscientists - Oertel - 2016 - Journal of Neurochemistry - Wiley Online Library
![Are There Benefits in Adding Catechol-O Methyltransferase Inhibitors in the Pharmacotherapy of Parkinson's Disease Patients? A Systematic Review - IOS Press Are There Benefits in Adding Catechol-O Methyltransferase Inhibitors in the Pharmacotherapy of Parkinson's Disease Patients? A Systematic Review - IOS Press](https://content.iospress.com/media/jpd/2018/8-2/jpd-8-2-jpd171225/jpd-8-jpd171225-g001.jpg?width=755)
Are There Benefits in Adding Catechol-O Methyltransferase Inhibitors in the Pharmacotherapy of Parkinson's Disease Patients? A Systematic Review - IOS Press
![Long term motor complications of levodopa: clinical features, mechanisms, and management strategies | Postgraduate Medical Journal Long term motor complications of levodopa: clinical features, mechanisms, and management strategies | Postgraduate Medical Journal](https://pmj.bmj.com/content/postgradmedj/80/946/452/F3.large.jpg)
Long term motor complications of levodopa: clinical features, mechanisms, and management strategies | Postgraduate Medical Journal
![Expert Perspectives – Parkinson's Disease Pathophysiology and Management | [current-page:pager]touchNEUROLOGY Expert Perspectives – Parkinson's Disease Pathophysiology and Management | [current-page:pager]touchNEUROLOGY](https://www.touchneurology.com/wp-content/uploads/sites/3/2018/06/figure3-pharmacological-systems.png)
Expert Perspectives – Parkinson's Disease Pathophysiology and Management | [current-page:pager]touchNEUROLOGY
![Levodopa-induced plasticity: a double-edged sword in Parkinson's disease? | Philosophical Transactions of the Royal Society B: Biological Sciences Levodopa-induced plasticity: a double-edged sword in Parkinson's disease? | Philosophical Transactions of the Royal Society B: Biological Sciences](https://royalsocietypublishing.org/cms/asset/21a073fc-217b-4dda-8033-715f00af937c/rstb20140184f01.jpg)
Levodopa-induced plasticity: a double-edged sword in Parkinson's disease? | Philosophical Transactions of the Royal Society B: Biological Sciences
![Levodopa - Pharmacokinetics, Mechanism of Action, Adverse Effects, Uses, Dose, Interactions | Antiparkinsonian Drugs | Pharmacology Levodopa - Pharmacokinetics, Mechanism of Action, Adverse Effects, Uses, Dose, Interactions | Antiparkinsonian Drugs | Pharmacology](http://www.pharmacy180.com/media/imgph02/gLky3Mx.jpg)
Levodopa - Pharmacokinetics, Mechanism of Action, Adverse Effects, Uses, Dose, Interactions | Antiparkinsonian Drugs | Pharmacology
![Long term motor complications of levodopa: clinical features, mechanisms, and management strategies | Postgraduate Medical Journal Long term motor complications of levodopa: clinical features, mechanisms, and management strategies | Postgraduate Medical Journal](https://pmj.bmj.com/content/postgradmedj/80/946/452/F1.large.jpg?width=800&height=600&carousel=1)
Long term motor complications of levodopa: clinical features, mechanisms, and management strategies | Postgraduate Medical Journal
![Foslevodopa/Foscarbidopa: A New Subcutaneous Treatment for Parkinson's Disease - Rosebraugh - 2021 - Annals of Neurology - Wiley Online Library Foslevodopa/Foscarbidopa: A New Subcutaneous Treatment for Parkinson's Disease - Rosebraugh - 2021 - Annals of Neurology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/dff51743-f157-41dc-88e5-d8b544c443fd/ana26073-fig-0001-m.jpg)